Home > Healthcare > Pharmaceuticals > Finished Drug Form > Albumin Market

Albumin Market Share

Report ID: GMI8342
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Albumin Market Share

The albumin industry is characterized by several key players, including global pharmaceutical companies, biotechnology firms, and specialized manufacturers. Companies like CSL Behring, Grifols, Baxter International Inc., Octapharma and China Biologic Products Holdings, Inc. significant contributors to the albumin business. These companies compete based on factors such as product quality, innovation, pricing, distribution networks, and regulatory compliance.

Albumin Market Companies

Key players operating in the albumin industry include:

Albumedix Ltd
Akron Biotech
Baxter International Inc.
Bristol-Myers Squibb Company
China Biologic Products Holdings Inc.
CSL Behring LLC
Grifols (Biotest AG)
Merck & Co., Inc.
Octapharma AG
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of albumin was reached USD 5.6 billion in 2023 and is set to register 6.5% CAGR from 2024 to 2032, driven by an increasing prevalence of chronic diseases and growing non-therapeutic applications of albumin.

Human serum albumin market held 82.6% revenue share in 2023 and is set to gain traction by 2032, attributed to its extensive therapeutic applications, biocompatibility, and safety profile.

North America albumin market is anticipated to reach USD 3.9 billion by the end of 2032, attributed to its advanced healthcare infrastructure, thriving pharmaceutical industry, high prevalence of chronic diseases, and stringent regulatory environment.

Albumedix Ltd, Akron Biotech, Baxter International Inc., Bristol-Myers Squibb Company, China Biologic Products Holdings Inc., CSL Behring LLC, Grifols (Biotest AG), Merck & Co., Inc., Octapharma AG are some of the major industry contenders.